The Drug-Induced Respiratory Disease Website and App

I. Interstitial/parenchymal lung disease

I.a Pneumonitis (interstitial lung disease/ILD)

I. Interstitial/parenchymal lung disease

I.g Pulmonary fibrosis

I. Interstitial/parenchymal lung disease

I.k Exogenous lipoid pneumonia (subacute, acute)

I. Interstitial/parenchymal lung disease

I.aa An area or areas of consolidation

I. Interstitial/parenchymal lung disease

I.af Hydrocarbon pneumonitis

I. Interstitial/parenchymal lung disease

I.ag Chemical (toxic) pneumonitis

I. Interstitial/parenchymal lung disease

I.ah Fire-eater's lung/pneumonitis

XLI. Pulmonary edema - Acute lung injury - ARDS

XLI.e ARDS - Acute lung injury

XLII. Pulmonary/alveolar./airway hemorrhage/bleeding

XLII.a Alveolar hemorrhage (AH), diffuse AH (DAH)

XLII. Pulmonary/alveolar./airway hemorrhage/bleeding

XLII.c Hemoptysis

XLIII. Airway involvement

XLIII.j Bronchiectasis

XLIV. Central-large-upper airway (incl. pharyngeal-nasal) involvement

XLIV.i Thermal (burns, frostbite), chemical or caustic injury on the face, mouth, tongue, pharynx or upper airway

XLV. Pleural and/or pericardial involvement

XLV.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

L. Miscellaneous

L.b Chest pain (acute or subacute), lone or prominent

L. Miscellaneous

L.p Sniffing death - Death from inhalation of compound

LIII. Hemoglobinopathies - Abnormal hemoglobin states (acquired)

LIII.a Methemoglobinemia

LV. Imaging

LV.b Imaging: Ground-glass opacities (GGO) / shadowing

LV. Imaging

LV.f Imaging: Bibasilar opacities/shadowing

LV. Imaging

LV.k Imaging: An area or areas of consolidation

LV. Imaging

LV.ac Imaging: Cavitating/cavitary lung nodule, mass or nodules (see also Iq, XIs, XIIi, XVIaa and XVIIp)

LV. Imaging

LV.ai Imaging: Pneumatoceles (see also XVIaf)

LV. Imaging

LV.aj Imaging: Pneumatocele or pneumatoceles

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.a BAL: An excess proportion of lymphocytes

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.h BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages

LVIII. Pathology

LVIII.cd Path: Fire eater's lung

LIX. Infections & related conditions

LIX.p Lung abscess/abscesses (see also VIr)

XLVI. Pulmonary vasculopathy

XLVI.e Fat/oil embolism - The FES embolism syndrome

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.h BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages

LVIII. Pathology

LVIII.be Path: Lipid/fat embolism (see also VIe)

I. Interstitial/parenchymal lung disease

I.a Pneumonitis (interstitial lung disease/ILD)

I. Interstitial/parenchymal lung disease

I.g Pulmonary fibrosis

I. Interstitial/parenchymal lung disease

I.k Exogenous lipoid pneumonia (subacute, acute)

I. Interstitial/parenchymal lung disease

I.l Lung nodule or nodules

I. Interstitial/parenchymal lung disease

I.t A mass or masses

I. Interstitial/parenchymal lung disease

I.aa An area or areas of consolidation

I. Interstitial/parenchymal lung disease

I.aq Paraffinoma - Lipidoma (ELP in the form of a nodule or mass)

XLI. Pulmonary edema - Acute lung injury - ARDS

XLI.e ARDS - Acute lung injury

XLII. Pulmonary/alveolar./airway hemorrhage/bleeding

XLII.c Hemoptysis

XLIII. Airway involvement

XLIII.r Plugs/casts in the airways

XLVII. Mediastinal involvement

XLVII.p Lipid-laden mediastinal lymphadenopathy

XLIX. Systemic/Distant conditions, syndromes and reactions

XLIX.e Autoimmunity-Autoimmune conditions (+ANA, +anti-ds-DNA, +ANCAs, other auto-Abs)

LV. Imaging

LV.a Imaging: Diffuse haze

LV. Imaging

LV.b Imaging: Ground-glass opacities (GGO) / shadowing

LV. Imaging

LV.f Imaging: Bibasilar opacities/shadowing

LV. Imaging

LV.i Imaging: An area or areas of involvement with a recognizable anatomic distribution

LV. Imaging

LV.k Imaging: An area or areas of consolidation

LV. Imaging

LV.n Imaging: Intralobular septal thickening - Crazy paving

LV. Imaging

LV.r Imaging: An area or areas of involvement with low attenuation numbers

LV. Imaging

LV.w Imaging: Lung nodule or nodules

LV. Imaging

LV.aa Imaging: A large nodule or a mass

LV. Imaging

LV.ac Imaging: Cavitating/cavitary lung nodule, mass or nodules (see also Iq, XIs, XIIi, XVIaa and XVIIp)

LV. Imaging

LV.bb Imaging: Solitary pulmonary nodule

LV. Imaging

LV.be Imaging: Intrathoracic lymph node enlargement

LVI. Distinctive patterns - 'Eye-catchers'

LVI.r Eye catcher: A milky, cloudy or lumpy BAL fluid

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.a BAL: An excess proportion of lymphocytes

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.h BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.j BAL: Free exogenous lipids in supernatant

LVIII. Pathology

LVIII.f Path: ILD with a granulomatous component (see also Im)

LVIII. Pathology

LVIII.v Path: NSIP-fibrotic pattern

LVIII. Pathology

LVIII.z Path: Exogenous lipoid pneumonia

LVIII. Pathology

LVIII.ab Path: Foreign body deposits/granulomatous reaction

LVIII. Pathology

LVIII.de Path: Exogenous lipid-laden lymphadenopathy

LIX. Infections & related conditions

LIX.h Nontuberculous pulmonary mycobacterial infection/superinfection

LX. Neoplastic conditions

LX.a Lung cancer

LXV. Veterinary medicine

LXV.c Veterinary: Exogenous lipoid pneumonia

I. Interstitial/parenchymal lung disease

I.k Exogenous lipoid pneumonia (subacute, acute)

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.h BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages

I. Interstitial/parenchymal lung disease

I.k Exogenous lipoid pneumonia (subacute, acute)

I. Interstitial/parenchymal lung disease

I.aq Paraffinoma - Lipidoma (ELP in the form of a nodule or mass)

XLIV. Central-large-upper airway (incl. pharyngeal-nasal) involvement

XLIV.i Thermal (burns, frostbite), chemical or caustic injury on the face, mouth, tongue, pharynx or upper airway

XLIX. Systemic/Distant conditions, syndromes and reactions

XLIX.w Multiple organ dysfunction/failure (MODS/MOF)

LI. Cardiovascular involvement / toxicity

LI.n Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)

LVII. Cytological, biochemical features of/in BAL, pleural fluid or FNA

LVII.h BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages

LVIII. Pathology

LVIII.z Path: Exogenous lipoid pneumonia